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The aim of the present study was to compare antioxidant capacities and structural changes of albumin in nonobese OSA patients and healthy volunteers.
Albumin structural changes were studied by quenching of fluorescence in the presence of acrylamide. Albumin thiols and fructosamines, reflecting oxidation-and glycation-induced changes in serum albumin, respectively, were assessed. Albumin structural changes were demonstrated by a significant decrease in quenching of fluorescence in OSA patients. Oxidation, resulting in a significant decrease in thiol groups (3.7¡0.7 versus 2.3¡0.4 mmol?g ), were found when comparing healthy volunteers with OSA patients. There was a significant relationship between both parameters and sleep apnoea severity. After continuous positive airway pressure intervention, albumin thiol groups were reassessed in seven of the 16 OSA patients and increased significantly from 2.25¡0.39 to 2.79¡0.31 mmol?g -1 protein.
Obstructive sleep apnoea patients demonstrated a reduction in serum albumin antioxidant properties that may aggravate oxidative stress and, thus, contribute to cardiovascular and metabolic morbidities.
KEYWORDS: Albumin, antioxidant properties, obstructive sleep apnoea, oxidative stress, protein glycation, thiols O bstructive sleep apnoea (OSA) syndrome is characterised by recurrent episodes of partial or complete pharyngeal collapse (hypopnoeas or apnoeas) occurring during sleep. It is a growing health concern affecting up to 5% of middle-aged males and females in the general population [1] . This is a serious health hazard, being recognised as an independent risk factor for hypertension, arrhythmias and coronary heart disease [2, 3] . People with OSA have a night-time peak in occurrence of sudden death, and an increased rate of cardiovascular morbidity and mortality [2, 3] .
The desaturation-reoxygenation sequence is a typical pattern coupled with the majority of respiratory events. This sequence leads to oxidative stress with production of reactive oxygen species (ROS) [4] . Numerous studies have demonstrated increased oxidative stress in OSA using various biological markers, although comorbidities, such as diabetes, hypertension or obesity, may account for part of these results [4] [5] [6] [7] . The increased levels of ROS contribute to the generation of adhesion molecules [8] , activation of leukocytes [9] and production of systemic inflammation [10] . In combination, these mechanisms generate vascular endothelium damage. Moreover, high sympathetic output, as consistently found in OSA, may lead to insulin resistance even in nonobese OSA patients [11] , thus representing an additional source of oxidative stress.
Oxidative stress is characterised by an imbalance between the production and degradation of ROS. While numerous studies have addressed the issue of increased ROS production, only a limited number of studies have addressed the role of antioxidant capacities in OSA patients. BARCELÓ et al. [12] reported an alteration in antioxidant capacities, with a reduction in total antioxidant status (TAS) and a decrease in vitamin A and vitamin E levels in OSA patients. In the same study, continuous positive airway pressure (CPAP) treatment normalised TAS [12] .
Albumin represents the most abundant protein in the circulatory system with a significant antioxidant activity, which is principally related to the protein's capacity to bind metal ions and scavenge free radicals [13] [14] [15] . It has been demonstrated that, besides its plasma concentration, structural modifications induced by glucose or free radicals impaired the antioxidant properties of albumin. The current hypothesis was that antioxidant defences mediated by albumin might be altered in OSA patients, as exposure to oxidative stress and insulin resistance are both parts of the disease.
In order to test this hypothesis, both the antioxidant capacity and the structural changes of serum albumin were investigated in selected OSA patients with a body mass index (BMI) f30 kg?m -2 and in healthy volunteers serving as a control group.
METHODS

Study population
In total, 23 subjects were studied: seven healthy volunteers and 16 OSA patients. The healthy volunteers were recruited from the staff of the University Hospital Grenoble (Grenoble, France). Patients were recruited according to the presence of OSA syndrome and a BMI f30 kg?m -2 . Patients were nondiabetic, nonsmoking, lean subjects. They were free of cardiovascular symptoms and medications. Cardiovascular examinations, including blood pressure measurements and ECG, were normal. Current smoking was an exclusion criterion as it would potentially induce oxidative stress. Ethical approval was obtained from the local ethics committee at the University Hospital Grenoble (Grenoble). All of the participants gave written informed consent. All participants underwent sleep studies and an assessment of different biological parameters as follows.
Sleep studies
Polysomnographic recordings were performed and scored following standard criteria [16] . Airflow was measured via nasal pressure, associated with the sum of the buccal and nasal thermistor signals. Respiratory efforts were monitored with abdominal and thoracic bands. An additional signal of respiratory effort (i.e. pulse transit time) was recorded concurrently. Arterial oxygen saturation (Sa,O 2 ) was measured using a pulse oximeter (Biox-Ohmeda 37001; Ohmeda, Liberty Corner, NJ, USA). An apnoea was defined as a complete cessation of airflow for o10 s. A hypopnoea was a reduction of o50% in the nasal pressure signal for o10 s, or a decrease of 30-50% in the nasal pressure signal for o10 s combined with either oxygen desaturation of o3% or an electroencephalogram (EEG) arousal (defined according to the American Academy of Sleep Medicine report) [16] . Apnoeas were classified as obstructive, central or mixed according to the presence or absence of respiratory efforts. The classification of hypopnoeas as obstructive or central was based upon the pulse transit time signal and the shape of the inspiratory part of nasal pressure (flow-limited aspect or not). An apnoea/hypopnoea index (AHI) was calculated and defined as the number of apnoeas and hypopnoeas per hour of sleep (full polysomnography) or per hour of recording (polysomnography without EEG recording). Sleep apnoea was defined as an AHI o15 events?h -1 .
Biological parameters
Metabolic parameters
Glucose, triglycerides, total cholesterol, high-and low-density lipoprotein (HDL and LDL, respectively) cholesterol were measured enzymatically on a Modular 700 automated analyser (Roche Diagnostics, Meylan, France). Insulin was measured using a radio-immunometric sandwich assay (CIS Bio International, Gif-sur-Yvette, France) with two monoclonal antibodies. The homeostasis model assessment (HOMA) was calculated using the following formula:
HOMA5(fasting serum insulin (munits?mL -1 ) 6 fasting blood glucose (mmol?L -1 ))/22.5
None of the present study patients exhibited diabetes, defined as fasting venous plasma glucose level o7.0 mmol?L -1 .
Oxidative stress characterisation: urinary 8-isoprostaglandin F2a type III assays Urinary 8-isoprostaglandin (iP)F2a type III measurements were performed by enzyme immunoassay to provide a marker of oxidative stress. Urine samples were kept refrigerated during the collection period, after which they were transferred to the laboratory, aliquoted and stored at -20uC. They were extracted on a solid phase extraction workstation using ISOLUTE C18 (EC) cartridges at 100 mg/10 mL (International Sorbent Technology, Hengoed, UK). Solid phase eluates of urine samples were tested using validated enzyme immunoassays. Polyclonal antiserum for iPF2a-III, and standard and acetylcholinesterase tracers were provided from Cayman Chemical (Ann Arbor, MI, USA). The assays were derived from a standard competition immunoassay procedure using microtitre plates pre-coated with mouse antirabbit immunoglobulin G (96-well plates).
Albumin structural changes, glycation and oxidation After isolating albumin from human plasma, its structural changes, glycation and oxidation were studied ( fig. 1) . A schematic representation of the glycation-and oxidationinduced changes in the structure and properties of human serum albumin (HSA) are shown in figure 1, adapted from BOURDON et al. [17] .
Isolation of albumin from human plasma Blue Sepharose TM 6 Fast Flow (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was used to purify plasma albumin. The gel was first washed with 50 mM Tris HCl buffer (pH 7.4) containing 0.5 M NaCl, and packed into a column of 1.5 cm diameter, 4 cm height. The column was equilibrated with five bed volumes of 50 mM Tris HCl, 0.5 M NaCl buffer. The gel was then transferred into 5-mL tubes and the technique of batch separation was used to obtain solutions of purified and concentrated albumin from plasma. Briefly, plasma (1.35 mL) was applied to the gel (2.5 mL). After the first centrifugation (4,0006g for 10 min at 4uC), the supernatant was eliminated. The gel was washed three times with the starting buffer, in the same conditions. The gel-bound albumin was eluted in 650 mL with 50 mM Tris HCl buffer (pH 7.4) containing 1.5 M NaCl. The tightly bound proteins were removed with 0.5 M NaSCN and the gel was re-equilibrated with three bed volumes of starting buffer.
Quenching of fluorescence
The albumin intrinsic fluorescence and quenching of fluorescence in the presence of acrylamide could be used [17] since HSA contains two tryptophan residues (Trp 218 and Trp 134), which generate autofluorescence. Moreover, it was previously shown that acrylamide does not alter the protein conformation [17] . Fluorescence measurements were performed using an LS 50 fluorimeter (PerkinElmer, Courtaboeuf, France) at excitation and emission wavelengths of 278 and 343 nm, respectively. Acrylamide was used as a quencher agent and was added to albumin solution in final concentration of 20 g?L -1 in 0.5 M phosphate buffer (pH 7.4), to a final concentration up to 60 mM acrylamide. The results are expressed as mean values of I0/I (Stern-Volmer constant, Kq), where I0 was albumin fluorescence before adding the quencher and I was the albumin fluorescence after adding the quencher.
Measurement of albumin thiol groups
HSA contains one free cysteine-derived, redox-reactive thiol group (Cys 34). Due to its reactive properties, the Cys 34 thiol moiety confers to HSA a major role in serum antioxidant capacity. Albumin thiols account for 80% (500 mmol?L -1 ) of the thiols in plasma [18] .
The measurement of thiol groups was performed using Ellman's reagent. Briefly, 2.5 mM 5,59-dithiobis(2-nitrobenzoic acid) in 0.2 M phosphate buffer, pH 8.0, was mixed with 500 mL of sample and 750 mL of 50 mM phosphate buffer, pH 8.0, and baseline absorbance was recorded at 412 nm. Following this, 250 mL of freshly prepared Ellman's reagent was added, the reaction was allowed to proceed for 15 min at room temperature in the dark, and the final absorbance was measured. HSA thiol group values were expressed in mmol?g -1 protein using a molar absorption coefficient of 13,600 L?mol Albumin thiol groups were reassessed after 15¡4 months of CPAP intervention in seven of the 16 OSA patients.
Measurement of plasma fructosamines
Plasma fructosamines were measured on a Modular 700 automated analyser (Roche Diagnostics).
Statistical analysis Sample size power calculation
In a previous study [14] , type 2 diabetic patients showed a 0.7¡0.48 difference in thiol groups between patients and controls. As the present OSA patients were supposed to be only suffering from insulin resistance, a mean difference of 0.6 with the same SD was expected. A total of seven healthy volunteers and 15 OSA patients provided a power of 0.80 with a value of a50.05.
The normality of the data distribution was assessed. Continuous data were expressed as mean¡SD. Relationships between the continuous variables were evaluated by Pearson's or Spearman's correlation analysis when data were not normally distributed. Differences in average for the SternVolmer constants between the two groups and according to the different acrylamide concentrations were determined by twofactor repeated measure ANOVA. Comparisons of two continuous variables were made with unpaired t-tests, except when comparing OSA patients before and after CPAP treatment, when paired t-tests were used. The MannWhitney U-test was used when the data were not normally distributed. Both univariate and multivariate analysis were performed, in order to assess the respective contribution of different factors in explaining the variance in albumin thiols and fructosamines. Multivariate analysis included all the variables potentially influencing the studied variable: AHI, 
RESULTS
Anthropometric, sleep and metabolic parameters
Healthy volunteers (n57) and OSA patients (n516) were similar in age but did show differences in BMI ( between this measurement of oxidative stress and changes detected in serum albumin.
HSA structural changes, oxidation and glycation Structural changes as assessed by quenching of fluorescence in the presence of acrylamide Fluorescence of HSA could be quenched by increasing concentrations of acrylamide ( fig. 2) . The quasi-linearity of the plots indicated that the quenching process followed a collision type. The Stern-Volmer curves, representing tryptophan accessibility to the quencher, were significantly different for the different albumin preparations tested when comparing healthy volunteers and OSA patients, (p,0.001, ANOVA). The magnitude of the increase in Stern-Volmer constant with higher acrylamide concentrations was blunted in OSA patients compared with healthy volunteers (p,0.001, ANOVA).
Oxidation of HSA evaluated by analysis of albumin thiol groups OSA patients exhibited a significant decrease in albumin thiol groups compared with healthy volunteers (2.3¡0.4 versus 3.7¡0.7 mmol?g -1 protein, respectively; p,0.001; fig. 3a ). There was a significant relationship between albumin thiols and AHI (r5 -0.71, p,0.001; fig. 3b ) and albumin thiols and mean nocturnal Sa,O 2 (r50.45, p,0.05; fig. 3c ). There was a significant negative correlation between thiol groups and HOMA index (r5 -0.47, p,0.02).
HSA glycation as measured by fructosamine levels
There was a significant increase in fructosamines when comparing healthy volunteers and OSA patients (226.6¡27 versus 286¡44.4 mmol?L -1 , respectively; p,0.001; fig. 4a ). Significant correlations were found between fructosamines and AHI (r50.62, p,0.001; fig. 4b ) and between fructosamines HV OSA *** and mean nocturnal Sa,O 2 (r5 -0.52, p,0.01; fig. 4c ). There was also a significant correlation between fructosamines and HOMA index (r50.52, p,0.01).
There were close correlations between Stern-Volmer constants and both albumin oxidation and glycation (albumin thiols: r50.85, p,0.001; fructosamines: r5 -0.77, p,0.001; fig. 5 ).
Multivariate analysis Albumin thiols
Univariate linear regression demonstrated that AHI, BMI, HOMA index and systolic blood pressure contributed to 50, 34, 29 and 17% of albumin thiols variance, respectively. Multivariate analysis showed that AHI had an independent effect on albumin thiols (p,0.04). Conversely, BMI was not an independent factor (p50.37).
Plasma fructosamines
Univariate linear regression demonstrated that AHI, BMI and HOMA index contributed to 39, 33 and 59% of albumin thiols variance, respectively. Multivariate regression analysis showed that only the HOMA index had an independent effect on plasma fructosamines (p50.01), while AHI was not an independent factor.
Effects of CPAP intervention
After a mean of 15¡4 months of CPAP intervention, albumin thiol groups were reassessed in seven of the 16 OSA patients, and had increased significantly from 2.25¡0.39 to 2.79¡0.31 mmol?g -1 protein (p,0.001; fig. 6 ).
DISCUSSION
For the first time, a decrease in serum albumin antioxidant capacities has been demonstrated in nonobese OSA patients, when compared with healthy volunteers. This impaired antioxidant capacity was related to the severity of OSA as expressed both by AHI and the amount of nocturnal oxygen desaturation. Moreover, CPAP intervention significantly increased albumin thiol groups.
Quenching of fluorescence in the presence of acrylamide provided arguments for albumin structural changes. As more acrylamide was needed in apnoeic patients compared with healthy volunteers to obtain a given level of fluorescence, this demonstrated that tryptophan accessibility on serum albumin molecules was decreased in OSA. This reduced accessibility was explained by serum albumin structural changes occurring both via protein oxidation (decrease in thiols) and protein glycation (increase in fructosamines). It has been demonstrated in vitro that protein heating induces identical structural changes, closely associated with a progressive loss of antioxidant properties [15] . More specifically, negative correlations have been established between the number and availability of thiol groups and albumin antioxidant properties [15] .
The three main mechanisms linking sleep apnoea to cardiovascular diseases are: imbalance between ROS production and degradation [4] , a source of oxidative stress; metabolic dysfunction as expressed by insulin resistance [11] ; and chronic systemic inflammation [10] . The changes in albumin properties reported in the present study may be involved in all three mechanisms.
As HSA mainly works as a free radical scavenger [19] , the reduction in antioxidant activity shown in OSA in the present study leads to an increase in oxidative stress. In OSA, oxidative stress is related to OSA per se and also to cardiovascular and metabolic comorbidities [7] . As the study patients were free of such comorbidities, there was only a trend towards an increase in isoprostaglandins compared with controls, and no direct correlation was found between oxidative stress and albumin structural changes. However, the present results are in line with the previous demonstration of a negative correlation between OSA severity and antioxidant capacity as measured by TAS [12, 20] . TAS is a global measure of serum antioxidant properties, including different pathways; thus, one can hypothesise that changes in albumin antioxidant capacities are part of the explanation for TAS reduction.
In the present study, OSA subjects were free from diabetes but demonstrated altered insulin sensitivity, with a mean HOMA value significantly higher than controls. It is well known that insulin resistance is linked with oxidative stress and associated with reduced intracellular antioxidant defences [21] . In the present study, there was a significant relationship between the HOMA index and albumin oxidation as indicated by the decrease in thiol groups (r5 -0.47, p,0.02). In addition, the HOMA index was also associated with fructosamine increase (r5 -0.52, p,0.01). Elevated fructosamine levels, reflecting glycation of albumin, are recognised in diabetes mellitus as being associated with impairment in antioxidant capacity. The same type of effect is likely to be present in OSA. Glycated albumin has been demonstrated to be associated with cardiovascular changes, both in animal models [22] and in human diabetes [23] [24] [25] . It has also been shown in mice that endothelial cell damage caused by glycated albumin can be reversed by monoclonal antibodies specific to glycated albumin [22] . In diabetic patients, an increase in glycated albumin level has been reported to be associated with an increase in pulse pressure, a well studied marker of cardiovascular risk [23] . Glycated albumin has also been shown to be correlated with plasma markers of endothelial dysfunction and cell adhesion molecules [24] , both of which have already been described in OSA as potential major risk factors for cardiovascular morbidity [8, 26] . Glycated HSA is also able to increase proliferation as well as migration of vascular smooth muscle cells [25] . Additionally, these intermediate glycated products may lead to the formation of advanced glycation end products (AGEs). It has been recently demonstrated that AGE serum levels are increased in nondiabetic OSA patients, and are associated with the severity of the disease [27] . As the most abundant plasma protein exhibiting significant glycation, as demonstrated in the present study, albumin might contribute to AGE formation in severe OSA patients.
OSA patients also suffer from vascular inflammation. In the present study, hsCRP was significantly increased in OSA patients compared with healthy volunteers. In an in vitro cell model submitted to intermittent hypoxia, as well as in apnoeic patients, RYAN and co-workers [28, 29] demonstrated an increase in the pro-inflammatory cytokines tumour necrosis factor-a and interleukin (IL)-6, mediated by selective activation of the pro-inflammatory transcription factor nuclear factor (NF)-kB. Interestingly, albumin augments intracellular glutathione levels in lymphocytes and modulates activation of NF-kB [30] . A thiol-mediated reduction in serum albumin decreases glutathione levels, thus allowing NF-kB activation [30] . Glycated serum albumin also induces NF-kB activation in vascular smooth muscle cells, increases activity of p38 mitogen-activated protein (MAP) kinases leading to increased production of monocyte chemotactic protein (MCP)-1 and IL-6. Increased production of MCP-1 and IL-6 has also been reported in sleep apnoea [8] . Moreover, using an endothelial cell in vitro model, it has been shown that intermittent hypoxia activates p38 MAP kinases and pharmacological inhibition of p38 MAP kinases abolishes NF-kB activation [29] .
In conclusion, the present study demonstrated for the first time a decrease in albumin antioxidant properties in severe nonobese obstructive sleep apnoea patients. This was related to albumin oxidation and glycation, and appeared to be correlated with the severity of obstructive sleep apnoea and also with insulin sensitivity impairment. Moreover, this was reversible under effective therapy by continuous positive airway pressure. These changes contribute to an unfavourable balance between oxidative stress and antioxidant capacities and may also contribute to aggravation of systemic inflammation.
